Early open repair vs ultrasound surveillance
Early open repair leads to lower mortality ( compared with ultrasound surveillance (high certainty).
- HR 0.992 studies · 2226 participantsHigh
Early open repair leads to lower mortality ( compared with ultrasound surveillance (high certainty).
Early open repair showed no clear difference in costs (per participant) ( compared with ultrasound surveillance (moderate certainty).
Early endovascular repair showed no clear difference in mortality ( compared with ultrasound surveillance (low certainty).
Early endovascular repair showed no clear difference in costs ( compared with ultrasound surveillance (low certainty).
IPC plus pharmacological prophylaxis may leads to lower incidence of PEa (early postoperative period) compared with IPC alone (low certainty).
IPC plus pharmacological prophylaxis may leads to lower incidence of DVTc (early postoperative period) compared with IPC alone (low certainty).
It is very uncertain whether IPC plus pharmacological prophylaxis changes incidence of bleedingd (early postoperative period) compared with IPC alone (very low certainty).
It is very uncertain whether IPC plus pharmacological prophylaxis changes incidence of major bleedingf (early postoperative period) compared with IPC alone (very low certainty).
IPC plus pharmacological prophylaxis may leads to lower incidence of PEa (early postoperative period) compared with pharmacological prophylaxis alone (low certainty).
IPC plus pharmacological prophylaxis leads to lower incidence of DVTc (early postoperative period) compared with pharmacological prophylaxis alone (high certainty).
It is very uncertain whether IPC plus pharmacological prophylaxis changes incidence of bleedinge (early postoperative period) compared with pharmacological prophylaxis alone (very low certainty).
It is very uncertain whether IPC plus pharmacological prophylaxis changes incidence of major bleedingg (early postoperative period) compared with pharmacological prophylaxis alone (very low certainty).
Chronic DVT ‐ antiplatelet agents plus BMP may leads to lower recurrent VTE ‐ early, intermediate and long term compared with BMP plus placebo (low certainty).
It is very uncertain whether chronic DVT ‐ antiplatelet agents plus BMP changes recurrent VTE ‐ early and intermediate compared with BMP alone (very low certainty).
The findings closest to your search, judged one by one by TypeSafe's Jev model.